<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//ES//DTD journal article DTD version 5.1.0//EN//XML" "art510.dtd" []><article docsubtype="rev"><item-info><jid>PCL</jid><aid>731</aid><ce:pii>S0031-3955(10)00062-3</ce:pii><ce:doi>10.1016/j.pcl.2010.03.001</ce:doi><ce:copyright type="full-transfer" year="2010">Elsevier Inc.</ce:copyright></item-info><ce:floats><ce:table id="tbl1" frame="topbot" colsep="0" rowsep="0"><ce:label>Table 1</ce:label> <ce:caption><ce:simple-para>Cardiovascular adaptation from training</ce:simple-para></ce:caption><tgroup cols="2"><colspec colnum="1" colname="col1"/><colspec colnum="2" colname="col2"/><thead><row rowsep="1" valign="top"><entry>Type of Training</entry><entry>Training Adaptations</entry></row></thead><tbody><row valign="top"><entry>Endurance</entry><entry><ce:list><ce:list-item><ce:para>Increased oxygen use</ce:para></ce:list-item><ce:list-item><ce:para>Decreased peripheral vascular resistance</ce:para></ce:list-item><ce:list-item><ce:para>Increased stroke volume</ce:para></ce:list-item><ce:list-item><ce:para>Increased cardiac output</ce:para></ce:list-item><ce:list-item><ce:para>Volume overload&ndash;induced ventricular dilatation</ce:para></ce:list-item></ce:list></entry></row><row valign="top"><entry>Resistance</entry><entry><ce:list><ce:list-item><ce:para>No change in oxygen use</ce:para></ce:list-item><ce:list-item><ce:para>No change in cardiac output</ce:para></ce:list-item><ce:list-item><ce:para>Increased peripheral vascular resistance</ce:para></ce:list-item><ce:list-item><ce:para>Increased heart rate</ce:para></ce:list-item><ce:list-item><ce:para>Pressure overload&ndash;induced ventricular hypertrophy</ce:para></ce:list-item></ce:list></entry></row></tbody></tgroup></ce:table><ce:textbox id="tbox1"><ce:label>Box 1</ce:label><ce:caption><ce:simple-para>Conditions affecting the heart that increase young athletes&apos; risk for SCD</ce:simple-para></ce:caption><ce:textbox-body><ce:sections><ce:para><ce:list><ce:list-item><ce:para>Anomalous origin of coronary artery (second most common cause in the United States)</ce:para></ce:list-item><ce:list-item><ce:para>Aortic stenosis</ce:para></ce:list-item><ce:list-item><ce:para>Aortic dissection (usually complication in Marfan syndrome)</ce:para></ce:list-item><ce:list-item><ce:para>ARVC (most common cause in Italy)</ce:para></ce:list-item><ce:list-item><ce:para>Brugada syndrome (most prevalent in those of Asian descent)</ce:para></ce:list-item><ce:list-item><ce:para>HCM</ce:para></ce:list-item><ce:list-item><ce:para>Dilated cardiomyopathy</ce:para></ce:list-item><ce:list-item><ce:para>Coarctation of aorta</ce:para></ce:list-item><ce:list-item><ce:para>Congenital heart block (Mobitz type II, complete, or third degree)</ce:para></ce:list-item><ce:list-item><ce:para>Congenital or acquired long QT syndromes</ce:para></ce:list-item><ce:list-item><ce:para>Short QT syndrome</ce:para></ce:list-item><ce:list-item><ce:para>Coronary artery disease (rare in those younger than 35)</ce:para></ce:list-item><ce:list-item><ce:para>Restrictive cardiomyopathy</ce:para></ce:list-item><ce:list-item><ce:para>Endocarditis</ce:para></ce:list-item><ce:list-item><ce:para>Ehlers-Danlos syndrome</ce:para></ce:list-item><ce:list-item><ce:para>Mitral valve prolapse</ce:para></ce:list-item><ce:list-item><ce:para>Myocarditis</ce:para></ce:list-item><ce:list-item><ce:para>Pericarditis</ce:para></ce:list-item><ce:list-item><ce:para>Postoperative congenital heart disease</ce:para></ce:list-item><ce:list-item><ce:para>Status post heart transplant</ce:para></ce:list-item><ce:list-item><ce:para>Kawasaki disease (coronary artery abnormalities)</ce:para></ce:list-item></ce:list></ce:para></ce:sections></ce:textbox-body></ce:textbox><ce:textbox id="tbox2"><ce:label>Box 2</ce:label><ce:caption><ce:simple-para>The 12-element AHA recommendations for preparticipaton cardiovascular screening of competitive athletes</ce:simple-para></ce:caption><ce:textbox-body><ce:sections><ce:para><ce:list><ce:section-title>Personal history</ce:section-title><ce:list-item><ce:label>1.</ce:label><ce:para>Exertional chest pain/discomfort</ce:para></ce:list-item><ce:list-item><ce:label>2.</ce:label><ce:para>Unexplained syncope/near syncope (judged not to be neurocardiogenic or vasovagal, of particular concern when related to exertion)</ce:para></ce:list-item><ce:list-item><ce:label>3.</ce:label><ce:para>Excessive exertional and unexplained dyspnea/fatigue associated with exercise</ce:para></ce:list-item><ce:list-item><ce:label>4.</ce:label><ce:para>Prior recognition of a heart murmur</ce:para></ce:list-item><ce:list-item><ce:label>5.</ce:label><ce:para>Elevated systemic blood pressure</ce:para></ce:list-item></ce:list><ce:list><ce:section-title>Family history</ce:section-title><ce:list-item><ce:label>6.</ce:label><ce:para>Premature death (sudden and unexplained or otherwise) before age 50 because of heart disease in 1 or more relative</ce:para></ce:list-item><ce:list-item><ce:label>7.</ce:label><ce:para>Disability from heart disease in a close relative younger than 50</ce:para></ce:list-item><ce:list-item><ce:label>8.</ce:label><ce:para>Specific knowledge of certain cardiac conditions in family members: HCM or dilated cardiomyopathy, long QT syndrome, other ion channelopathies, Marfan syndrome, or clinically important arrhythmias</ce:para></ce:list-item></ce:list><ce:list><ce:section-title>Physical examination</ce:section-title><ce:list-item><ce:label>9.</ce:label><ce:para>Heart murmur (auscultation should be performed in supine and standing positions [or with Valsalva maneuver], specifically to identify murmurs of dynamic left ventricular outflow tract obstruction)</ce:para></ce:list-item><ce:list-item><ce:label>10.</ce:label><ce:para>Femoral pulses to exclude aortic coarctation</ce:para></ce:list-item><ce:list-item><ce:label>11.</ce:label><ce:para>Physical stigmata of Marfan syndrome</ce:para></ce:list-item><ce:list-item><ce:label>12.</ce:label><ce:para>Brachial artery blood pressure (sitting position) preferably taken in both arms</ce:para></ce:list-item></ce:list></ce:para></ce:sections></ce:textbox-body></ce:textbox><ce:textbox id="tbox3"><ce:label>Box 3</ce:label><ce:caption><ce:simple-para>Cardiovascular preparticipation screening history</ce:simple-para></ce:caption><ce:textbox-body><ce:sections><ce:para><ce:list><ce:section-title><ce:bold>Symptoms</ce:bold></ce:section-title><ce:list-item><ce:para>Unusual (more than or different from others) fatigue associated with physical activities</ce:para></ce:list-item><ce:list-item><ce:para>Pain, discomfort, or feeling of pressure in chest during exercise</ce:para></ce:list-item><ce:list-item><ce:para>Presyncope or syncope (fainting) during or after exercise, emotion, or startle</ce:para></ce:list-item><ce:list-item><ce:para>Exercise-associated dizziness</ce:para></ce:list-item><ce:list-item><ce:para>Exercise-associated shortness of breath</ce:para></ce:list-item><ce:list-item><ce:para>Heart racing or skipping beats</ce:para></ce:list-item></ce:list><ce:list><ce:section-title><ce:bold>Medical or personal history and review of systems</ce:bold></ce:section-title><ce:list-item><ce:para>Unexplained seizures or seizure-like episodes</ce:para></ce:list-item><ce:list-item><ce:para>Unexplained episodes of exercise-induced asthma or asthma-like symptoms</ce:para></ce:list-item><ce:list-item><ce:para>Recent febrile illness</ce:para></ce:list-item><ce:list-item><ce:para>Detailed history of any congenital structural heart disease</ce:para></ce:list-item><ce:list-item><ce:para>Use of a cardiac pacemaker or implanted cardiac defibrillator</ce:para></ce:list-item><ce:list-item><ce:para>History of Kawasaki disease</ce:para></ce:list-item><ce:list-item><ce:para>History of rheumatic fever</ce:para></ce:list-item><ce:list-item><ce:para>Known heart murmur</ce:para></ce:list-item><ce:list-item><ce:para>Known high cholesterol or lipid disorder</ce:para></ce:list-item><ce:list-item><ce:para>Systemic hypertension</ce:para></ce:list-item><ce:list-item><ce:para>Diabetes mellitus</ce:para></ce:list-item><ce:list-item><ce:para>Thyroid disease</ce:para></ce:list-item><ce:list-item><ce:para>Any previous recommendations to restrict physical activity</ce:para></ce:list-item><ce:list-item><ce:para>Use of therapeutic medications</ce:para></ce:list-item><ce:list-item><ce:para>Use of dietary supplements or over-the-counter medications</ce:para></ce:list-item><ce:list-item><ce:para>Substance abuse or tobacco use</ce:para></ce:list-item><ce:list-item><ce:para>Use of excessive caffeine or energy drinks</ce:para></ce:list-item></ce:list><ce:list><ce:section-title><ce:bold>Family history</ce:bold></ce:section-title><ce:list-item><ce:para>Sudden or unexpected death of family members before age 50 (include deaths due to possible sudden infant death syndrome, automobile accident, or drowning)</ce:para></ce:list-item><ce:list-item><ce:para>Coronary artery disease before age 50</ce:para></ce:list-item><ce:list-item><ce:para>Family members using pacemaker or implanted cardiac defibrillator</ce:para></ce:list-item><ce:list-item><ce:para>Family history of congenital deafness</ce:para></ce:list-item><ce:list-item><ce:para>Family history of certain cardiovascular diseases, such as Marfan syndrome, cardiomyopathies, long QT syndrome, short QT syndrome, or Brugada syndrome</ce:para></ce:list-item><ce:list-item><ce:para>Family history of lipid disorders, diabetes mellitus, or systemic hypertension</ce:para></ce:list-item><ce:list-item><ce:para>Family history of primary pulmonary hypertension</ce:para></ce:list-item></ce:list></ce:para></ce:sections></ce:textbox-body></ce:textbox></ce:floats><head><ce:title>Cardiovascular Screening of Adolescent Athletes</ce:title><ce:author-group><ce:author id="au1"><ce:given-name>Saad</ce:given-name><ce:surname>Siddiqui</ce:surname><ce:degrees>MD</ce:degrees><ce:cross-ref refid="aff1"><ce:sup>a</ce:sup></ce:cross-ref><ce:cross-ref refid="cor1"><ce:sup>&lowast;</ce:sup></ce:cross-ref><ce:e-address type="email">siddiq27@msu.edu</ce:e-address></ce:author><ce:author id="au2"><ce:given-name>Dilip R.</ce:given-name><ce:surname>Patel</ce:surname><ce:degrees>MD, FAAP, FACSM, FAACPDM, FSAM</ce:degrees><ce:cross-ref refid="aff2"><ce:sup>b</ce:sup></ce:cross-ref></ce:author><ce:affiliation id="aff1"><ce:label>a</ce:label><ce:textfn>Pediatric Cardiology, Hope Children&apos;s Hospital, 4440 West 95th Street, Oak Lawn, IL, USA</ce:textfn></ce:affiliation><ce:affiliation id="aff2"><ce:label>b</ce:label><ce:textfn>Department of Pediatrics and Human Development, Michigan State University College of Human Medicine, Kalamazoo Center for Medical Studies, 1000 Oakland Drive, Kalamazoo, MI 49024, USA</ce:textfn></ce:affiliation><ce:correspondence id="cor1"><ce:label>&lowast;</ce:label><ce:text>Corresponding author.</ce:text></ce:correspondence></ce:author-group><ce:abstract class="teaser"><ce:abstract-sec><ce:simple-para view="extended">A preparticipation cardiovascular screening is recommended for all athletes with the aim of identifying conditions that increase the risk for adverse cardiac event, including sudden death. History and physical examination are the mainstay of cardiovascular screening of young athletes. The ability to identify athletes at risk, however, based on history and physical examination alone is low, and inclusion of an electrocardiogram as a screening tool has been suggested to improve the sensitivity of screening. This article provides an overview of key aspects of cardiovascular screening currently recommended in the United States for young athletes.</ce:simple-para></ce:abstract-sec></ce:abstract><ce:keywords xml:lang="en"><ce:section-title>Keywords</ce:section-title><ce:keyword><ce:text>Young athletes</ce:text></ce:keyword><ce:keyword><ce:text>Electrocardiography</ce:text></ce:keyword><ce:keyword><ce:text>Sudden cardiac death</ce:text></ce:keyword><ce:keyword><ce:text>Preparticipation screening</ce:text></ce:keyword></ce:keywords></head><body><ce:sections><ce:para>Preparticipation screening of competitive athletes refers to the &ldquo;systematic practice of medically screening large populations of athletes before participation in sports for the purpose of identifying abnormalities that could provoke disease progression or sudden death.&rdquo;<ce:cross-ref refid="bib1"><ce:sup>1</ce:sup></ce:cross-ref> The main objective of screening is to identify athletes who have cardiovascular risk factors so that timely evaluation and management can be initiated and appropriate decisions made about the level of physical activity or sport participation.<ce:cross-refs refid="bib1 bib2 bib3 bib4 bib5 bib6"><ce:sup>1&ndash;6</ce:sup></ce:cross-refs></ce:para><ce:para>Screening and prevention are the most important strategies for several reasons.<ce:cross-refs refid="bib7 bib8 bib9 bib10 bib11 bib12 bib13"><ce:sup>7&ndash;13</ce:sup></ce:cross-refs> It is commonly believed that automated external defibrillators (AEDs) placed at strategic locations at athletic venues and public places will help in improving survival after a sudden cardiac arrest (SCA).<ce:cross-ref refid="bib7"><ce:sup>7</ce:sup></ce:cross-ref> Results of studies done to evaluate survival after an SCA on the athletic field with timely use of an AED by reasonably trained personnel are at best equivocal.<ce:cross-refs refid="bib7 bib8 bib9 bib10 bib11 bib12 bib13"><ce:sup>7&ndash;13</ce:sup></ce:cross-refs> Thirty percent to 50% of all sudden cardiac deaths (SCDs) are the first clinical manifestation of an underlying pathology.<ce:cross-ref refid="bib12"><ce:sup>12</ce:sup></ce:cross-ref> Various aspects related to cardiovascular screening of young athletes and SCD are subjects of a voluminous published research and excellent reviews, commentaries, and editorials.<ce:cross-refs refid="bib1 bib2 bib3 bib4 bib5 bib6 bib14 bib15 bib16 bib17 bib18 bib19 bib20 bib21"><ce:sup>1&ndash;6,14&ndash;21</ce:sup></ce:cross-refs> This article provides an overview of key aspects of cardiovascular screening currently recommended in the United States for young athletes. The main concern and impetus for such an intense focus on cardiovascular screening is the risk of SCD during sport participation.</ce:para><ce:section id="sec2"><ce:section-title>SCD</ce:section-title><ce:para>SCD refers to &ldquo;nontraumatic and unexpected sudden death that may occur from a cardiac arrest, within 6 hours of a previously normal state of health.&rdquo;<ce:cross-ref refid="bib3"><ce:sup>3</ce:sup></ce:cross-ref> In the modern era of competitive sports, there have been instances of athlete deaths in almost all sports but more commonly in basketball, soccer, and football.<ce:cross-refs refid="bib1 bib2 bib3 bib4"><ce:sup>1&ndash;4</ce:sup></ce:cross-refs> Sudden death in athletes is especially disconcerting because exercise has proved to decrease the risk of life-threatening cardiovascular disease.<ce:cross-ref refid="bib1"><ce:sup>1</ce:sup></ce:cross-ref></ce:para><ce:section id="sec2.1"><ce:section-title>Epidemiology</ce:section-title><ce:para>Although the exact incidence of SCD during sport participation in young athletes is not known, several studies provide an estimate of the incidence and data on other epidemiologic characteristics of SCD.<ce:cross-refs refid="bib1 bib2 bib3 bib4 bib5 bib6 bib22 bib23 bib24"><ce:sup>1&ndash;6,22&ndash;24</ce:sup></ce:cross-refs> The incidence of SCD is estimated to be 1 in 200,000 in high school athletes and 1 in 65,000 in collegiate athletes in the United States.<ce:cross-refs refid="bib1 bib2 bib3 bib4 bib5 bib6 bib22"><ce:sup>1&ndash;6,22</ce:sup></ce:cross-refs> The incidence of cardiovascular collapse as the cause of athletic fatalities is twice that of death caused by trauma.<ce:cross-refs refid="bib14 bib15"><ce:sup>14,15</ce:sup></ce:cross-refs> SCD is more common in men than in women at a ratio ranging from 5:1 to 9:1; this may be because of the higher participation rate in men in competitive sports.<ce:cross-refs refid="bib1 bib5 bib16"><ce:sup>1,5,16</ce:sup></ce:cross-refs> The incidence is higher in African American athletes; the disparity could be because of a higher number of competitive athletes (almost 40%) who are African American.<ce:cross-refs refid="bib1 bib5 bib23"><ce:sup>1,5,23</ce:sup></ce:cross-refs> In previous studies from Italy, the incidence of SCD in athletes was reported at 3 in 100,000.<ce:cross-refs refid="bib2 bib25"><ce:sup>2,25</ce:sup></ce:cross-refs> This difference between the United States and Italy is thought to be due to the younger age of the American athletes and the inclusion of a larger number of female athletes.<ce:cross-refs refid="bib2 bib18"><ce:sup>2,18</ce:sup></ce:cross-refs> In the United States, the most common sports associated with SCA are football, basketball, and ice hockey whereas in Europe it is soccer.<ce:cross-refs refid="bib1 bib2 bib3 bib4 bib5 bib6"><ce:sup>1&ndash;6</ce:sup></ce:cross-refs></ce:para></ce:section><ce:section id="sec2.2"><ce:section-title>Causes</ce:section-title><ce:para>Pathophysiology of SCD is explained by exercise acting as a trigger for precipitation of sometimes lethal arrhythmias in the presence of underlying structural heart diseases or other susceptibilities.<ce:cross-refs refid="bib1 bib2 bib3 bib4 bib5 bib6 bib25 bib26"><ce:sup>1&ndash;6,25,26</ce:sup></ce:cross-refs> In the United States, the most common cause of SCD in young athletes (26%) is hypertrophic cardiomyopathy (HCM).<ce:cross-refs refid="bib1 bib2 bib3 bib4 bib5 bib6 bib27 bib28 bib29 bib30 bib31"><ce:sup>1&ndash;6,27&ndash;31</ce:sup></ce:cross-refs> The second most frequent cause of SCD in athletes (14%) is anomalous origin of the coronary artery, most commonly the left coronary artery arising from the right sinus of Valsalva.<ce:cross-refs refid="bib32 bib33"><ce:sup>32,33</ce:sup></ce:cross-refs> This group of patients may have a completely normal electrocardiogram (ECG) and exercise stress test and first manifests symptoms with exertion while playing sport.<ce:cross-ref refid="bib32"><ce:sup>32</ce:sup></ce:cross-ref> Other heart-related conditions that increase the risk for SCA in young athletes are listed in <ce:cross-ref refid="tbox1">Box 1</ce:cross-ref><ce:float-anchor refid="tbox1"/>.<ce:cross-refs refid="bib1 bib2 bib3 bib4 bib5 bib6 bib10 bib11"><ce:sup>1&ndash;6,10,11</ce:sup></ce:cross-refs></ce:para><ce:para>In young children, commotio cordis is an important cause of sudden death. Commotios cordis results from a blunt trauma to the chest by a fast moving projectile, such as a baseball or ice hockey puck.<ce:cross-refs refid="bib10 bib11"><ce:sup>10,11</ce:sup></ce:cross-refs> The mechanism of cardiac arrest is ventricular fibrillation. The blow should be inflicted within a narrow window of time (within 10&ndash;30 milliseconds) just before the peak of the T wave during repolarization.<ce:cross-refs refid="bib1 bib10 bib11"><ce:sup>1,10,11</ce:sup></ce:cross-refs> Commotio cordis accounts for 20% of SCD in children on the field.<ce:cross-refs refid="bib1 bib10 bib11"><ce:sup>1,10,11</ce:sup></ce:cross-refs></ce:para></ce:section></ce:section><ce:section id="sec3"><ce:section-title>Cardiovascular screening</ce:section-title><ce:section id="sec3.1"><ce:section-title>History and Physical Examination</ce:section-title><ce:para>The current American Heart Association (AHA) recommendations for cardiovascular screening of competitive young athletes consist of a review of 12 items (<ce:cross-ref refid="tbox2">Box 2</ce:cross-ref><ce:float-anchor refid="tbox2"/>).<ce:cross-ref refid="bib1"><ce:sup>1</ce:sup></ce:cross-ref> A positive response to 1 or more of these items is considered an indication for additional cardiovascular evaluation. Information that should be ascertained in the cardiovascular screening history of young athletes is listed in <ce:cross-ref refid="tbox3">Box 3</ce:cross-ref><ce:float-anchor refid="tbox3"/>.<ce:cross-refs refid="bib1 bib2 bib3 bib4 bib5 bib6"><ce:sup>1&ndash;6</ce:sup></ce:cross-refs></ce:para><ce:para>In the United States there is no mandate or law regarding preparticipation screening. The responsibility of providing screening services for student athletes rests with the institutions organizing sports. Personal physicians are expected to conduct the 12-point screening evaluation in cases of high school athletes. At higher levels of athletic participation, it is the team physician who decides appropriate medical screening procedures.</ce:para><ce:para>In the United States, history and physical examination (H&amp;P) has been the standard of cardiovascular screening for competitive athletes, although several studies have questioned the efficacy of the screening H&amp;P alone in identifying athletes at risk for cardiovascular adverse events.<ce:cross-refs refid="bib1 bib4 bib18 bib34 bib35 bib36 bib37 bib38"><ce:sup>1,4,18,34&ndash;38</ce:sup></ce:cross-refs> A study of 134 cases of SCD who had undergone a screening H&amp;P reports that only 3% of patients were suspected of having cardiac disease and eventually only fewer than 1% received an accurate diagnosis.<ce:cross-ref refid="bib34"><ce:sup>34</ce:sup></ce:cross-ref> This conferred a low sensitivity to H&amp;P as a screening tool. The investigators also reported that at the high school level, the H&amp;P was not being administered as recommended by the AHA.<ce:cross-ref refid="bib34"><ce:sup>34</ce:sup></ce:cross-ref> The low sensitivity of the H&amp;P is partly explained by suboptimal ascertainment of information. Surveys have reported that a significant percentage of H&amp;P forms used by high schools do not include all 12 AHA-recommended screening items (see <ce:cross-ref refid="tbox2">Box 2</ce:cross-ref>). Another issue relates to who is responsible for administering the H&amp;P. H&amp;P is administered by professionals with different levels of qualifications. In 64% of states in the United States, nonphysicians can administer the H&amp;P.<ce:cross-ref refid="bib38"><ce:sup>38</ce:sup></ce:cross-ref> In cases of college athletics, 25% of colleges were judged to have inadequate screening H&amp;P forms. The National Collegiate Athletic Association H&amp;P form includes 10 of 12 items from the AHA recommendations.<ce:cross-ref refid="bib36"><ce:sup>36</ce:sup></ce:cross-ref></ce:para><ce:para>The H&amp;P has come under scrutiny for having low sensitivity for identifying athletes with cardiovascular risk factors. The most frequently reported causes of SCD in young athletes, HCM and anomalous origin of coronary artery, are generally asymptomatic and have normal findings on examination. The advantages of H&amp;P include cost effectiveness, need for minimal resources, and efficiency in administration with reasonable sensitivity. Several studies have reported data substantiating the higher&nbsp;efficacy of ECG in identifying athletes with HCM, channelopathies, and other clinically silent cardiovascular diseases that increase the risk for SCD in young athletes.<ce:cross-refs refid="bib18 bib20 bib21 bib25 bib28 bib39 bib40 bib41 bib42 bib43 bib44"><ce:sup>18,20,21,25,28,39&ndash;44</ce:sup></ce:cross-refs></ce:para></ce:section><ce:section id="sec3.2"><ce:section-title>Electrocardiogram</ce:section-title><ce:para>The 12-lead ECG obtained at rest on a nontraining day has received a lot of attention as a screening tool consequent to the Italian experience showing marked decrease in SCD rates after making ECG part of standard screening.<ce:cross-ref refid="bib44"><ce:sup>44</ce:sup></ce:cross-ref> The International Olympic Committee and the European Sports Council require an ECG before sports participation.<ce:cross-refs refid="bib2 bib20 bib21"><ce:sup>2,20,21</ce:sup></ce:cross-refs> Japan has been subjecting all first, seventh, and tenth graders to an ECG since 1973.<ce:cross-ref refid="bib40"><ce:sup>40</ce:sup></ce:cross-ref> An ECG is abnormal in 90% of patients with HCM.<ce:cross-refs refid="bib1 bib44"><ce:sup>1,44</ce:sup></ce:cross-refs> Other ECG detectable diseases causing SCD include arrythmogenic right ventricular cardiomyopathy (ARVC), ion channelopathies, dilated cardiomyopathy, and Wolff-Parkinson-White syndrome (WPW).<ce:cross-refs refid="bib44 bib45"><ce:sup>44,45</ce:sup></ce:cross-refs></ce:para><ce:para>Corrado and colleagues<ce:cross-ref refid="bib28"><ce:sup>28</ce:sup></ce:cross-ref> showed that they were able to identify 22 asymptomatic athletes (of 33,735 athletes screened) with HCM based on screening ECG, later confirmed with an echocardiogram (ECHO). Eighty-two percent of the patients had abnormal ECG whereas 23% had some suggestions of underlying disease based on family history, a murmur, or both. In an extension of that, Corrado and colleagues<ce:cross-refs refid="bib20 bib39"><ce:sup>20,39</ce:sup></ce:cross-refs> showed an 89% decrease in the incidence of SCD in athletes screened with ECG in Italy. A study of more than 5000 Nevada high school athletes showed the sensitivity of ECGs at 78% in detecting athletes at risk; this compares to 3% sensitivity for the H&amp;P alone.<ce:cross-ref refid="bib38"><ce:sup>38</ce:sup></ce:cross-ref> The specificity seems to increase when ECG changes considered grossly abnormal are pursued with additional studies.</ce:para><ce:para>In the United States, routine ECG is not currently recommended as part of cardiovascular screening of young asymptomatic athletes.<ce:cross-refs refid="bib1 bib3"><ce:sup>1,3</ce:sup></ce:cross-refs> Reasons cited for not including ECG include cost, need for trained personnel, need for appropriate infrastructure, false-positive findings (in 10%&ndash;40%) warranting further unnecessary testing, and potential to cause anxiety in otherwise healthy athletes and their families.<ce:cross-refs refid="bib1 bib3 bib4 bib46"><ce:sup>1,3,4,46</ce:sup></ce:cross-refs> Current recommendations include improving and standardizing the existing H&amp;P forms, thus improving their yield, and creating a national data registry for reporting SCDs to better assess the epidemiology of SCD in the US athletic population. Because SCD is a rare event in young athletes, with a large number of athletes (5&ndash;10 million), it is estimated that it would cost $3.4 million to save 1 athlete&apos;s life from SCD and $330,000 to identify 1 athlete at risk for SCD.<ce:cross-ref refid="bib1"><ce:sup>1</ce:sup></ce:cross-ref> The sensitivity of the screening ECG depends on appropriate interpretation by qualified professionals. The knowledge of specific ECG findings in healthy adolescents and ECG changes in athletes is imperative to determine what constitutes an abnormal and clinically significant change.<ce:cross-refs refid="bib44 bib47 bib48 bib49"><ce:sup>44,47&ndash;49</ce:sup></ce:cross-refs></ce:para><ce:para>There have been several questions raised regarding the Italian experience, which is cited most frequently as the basis for including ECG as a screening tool. One argument against that study is that it is an observational study and not a prospective study with a control population.<ce:cross-ref refid="bib1"><ce:sup>1</ce:sup></ce:cross-ref> Also, the incidence rates that the Italians have managed to achieve after almost 25 years of ECG screening are not significantly different from the existing SCD rates in the United States.</ce:para><ce:para>Myerburg and Vetter<ce:cross-ref refid="bib41"><ce:sup>41</ce:sup></ce:cross-ref> make several points in favor of including ECG for cardiovascular screening of competitive athletes. They contend that the false-positive rate of 10% to 25% cited in the AHA recommendations for abnormal findings on ECG is too high and according to their estimate it is approximately 4.8%.<ce:cross-refs refid="bib41 bib42"><ce:sup>41,42</ce:sup></ce:cross-refs> Myerburg and Vetter<ce:cross-ref refid="bib41"><ce:sup>41</ce:sup></ce:cross-ref> have suggested that all school athletes receive ECGs only twice during their school athletic career. This would mitigate the need for annual ECG for each athlete and significantly bring down the cost of such a program. With regards to personnel, the argument is that ancillary health staff with an interest in SCA should be recruited and trained to provide for the numbers required for a functional screening strategy that includes ECG. Fuller and colleagues,<ce:cross-ref refid="bib38"><ce:sup>38</ce:sup></ce:cross-ref> based on their study of more than 5000 high school athletes, estimated that including an ECG in the screening protocol would cost $44,000 for each life saved. Fuller and colleagues<ce:cross-ref refid="bib38"><ce:sup>38</ce:sup></ce:cross-ref> report that screening 700,000 high school athletes annually results in 1080 years of life gained when an ECG is used compared with 92 years of life gained when the AHA-recommended H&amp;P alone is used. The average cost of screening in Japan is $8800 per life saved and in Italy a similar type of program cost $15,926 per life saved; both include screening ECG.<ce:cross-refs refid="bib43 bib50"><ce:sup>43,50</ce:sup></ce:cross-refs> With government subsidy and more realistic cost assessment, it has been surmised that a screening program with ECG can be put in place at 20% to 25% of the cost presented in the AHA report.<ce:cross-refs refid="bib1 bib41"><ce:sup>1,41</ce:sup></ce:cross-refs></ce:para><ce:para>Currently, there is no consensus regarding whether or not routine ECG screening is prudent to apply to the US athlete population. The AHA report provides the framework for cardiovascular screening.<ce:cross-refs refid="bib1 bib3"><ce:sup>1,3</ce:sup></ce:cross-refs> Large prospective studies are needed to evaluate the value of screening ECGs in the US population. In more recent publications, Maron and colleagues<ce:cross-refs refid="bib1 bib6"><ce:sup>1,6</ce:sup></ce:cross-refs> have reviewed the recommendations for and against including an ECG in preparticipation screening. Maron and colleagues<ce:cross-refs refid="bib1 bib6"><ce:sup>1,6</ce:sup></ce:cross-refs> note the potential usefulness of ECGs in identifying athletes at risk but also cite lack of infrastructure (including trained personnel) and the demographics of the athletic population as the principle barriers to implementing a large-scale screening program that includes ECG. Maron and colleagues<ce:cross-refs refid="bib1 bib6 bib22"><ce:sup>1,6,22</ce:sup></ce:cross-refs> in their study comparing the rate of SCD in similar-sized populations in Minnesota, United States, and Veneto, Italy, reported that the rate of SCD was not significantly different between the 2 groups. The investigators, however, note that the rate of SCD has declined in Veneto, Italy, after implementation of an ECG-based screening program. In Italy, a specialist who has received training for 4 years administers the sports screening. Such a person is well trained in reading ECG of athletes, decreasing the false-positive rates and keeping the costs down. Based on many reports, including that of the AHA, inclusion of an ECG in routine screening of asymptomatic young athletes presents considerable economic and logistical challenges. Therefore, at present, ECG is indicated based on abnormal findings of H&amp;P.</ce:para><ce:section id="sec3.2.1"><ce:section-title>Physiology and cardiac remodeling</ce:section-title><ce:para>Knowledge of cardiovascular changes that result from regular exercise is essential in the interpretation of ECG changes in athletes.<ce:cross-refs refid="bib44 bib51"><ce:sup>44,51</ce:sup></ce:cross-refs> The term, <ce:italic>athlete&apos;s heart</ce:italic>, refers to the changes that result from regular exercise, characterized by a benign increase in cardiac mass and specific circulatory and cardiac morphologic alterations that represent a physiologic adaptation to systematic training.<ce:cross-refs refid="bib47 bib49 bib51 bib52 bib53 bib54 bib55 bib56 bib57 bib58 bib59 bib60 bib61 bib62"><ce:sup>47,49,51&ndash;62</ce:sup></ce:cross-refs> Endurance training (dynamic, isotonic, or aerobic), such as running or swimming, and resistance training&nbsp;(static, isometric, or anaerobic), such as weight training, result in different training effects on the cardiovascular system (<ce:cross-ref refid="tbl1">Table 1</ce:cross-ref><ce:float-anchor refid="tbl1"/>).<ce:cross-ref refid="bib1"><ce:sup>1</ce:sup></ce:cross-ref> In most sports, however, there is some overlap of endurance and resistance training. This is exemplified in sports, such as skiing, rowing, cycling, and triathlon. It is, therefore, expected that with regular exercise training there is some combination of cardiac chamber dilation and increase in wall thickness.<ce:cross-ref refid="bib1"><ce:sup>1</ce:sup></ce:cross-ref></ce:para><ce:para>The cardiac remodeling associated with regular exercise training in athletes is not a uniform phenomenon. Fifty percent of athletes may show some cardiac remodeling that includes 1 or all of the following: increase left ventricle, right ventricle, or left atrium chamber size. Ventricular wall thickness may or may not be increased. These changes are usually associated with normal systolic and diastolic function. Remodeling may occur rapidly or more gradually. Most of these changes are still within normal limits when compared with age- and gender-matched sedentary individuals.<ce:cross-ref refid="bib47"><ce:sup>47</ce:sup></ce:cross-ref></ce:para><ce:para>The degree of structural change in the heart may correlate with the type of sport that an athlete is involved in, but this is not proved conclusively.<ce:cross-refs refid="bib48 bib49 bib52 bib53 bib54"><ce:sup>48,49,52&ndash;54</ce:sup></ce:cross-refs> The clinical variables that may play a role in influencing the degree of structural change in the heart include body size (50%), type of sport (14%), gender (7%), age (4%), and unknown factors (25%).<ce:cross-refs refid="bib48 bib49 bib50 bib51 bib52 bib53 bib54 bib55"><ce:sup>48&ndash;55</ce:sup></ce:cross-refs> Genetics also plays a role and may be responsible for some of the unknown variables.<ce:cross-refs refid="bib48 bib49 bib50 bib51 bib52 bib53 bib54 bib55"><ce:sup>48&ndash;55</ce:sup></ce:cross-refs></ce:para><ce:para>Often the changes in ventricular chamber size and wall thickness seen in competitive athletes may mimic structural heart disease. A ventricular wall thickness between 13 and 15 mm and left ventricular end-diastolic size greater than or equal to 55 mm but less than or equal to 60 mm constitute the gray zone of overlap between physiologic change and structural heart disease.<ce:cross-refs refid="bib1 bib3 bib48 bib55"><ce:sup>1,3,48,55</ce:sup></ce:cross-refs> In these cases, it is often difficult to make a decision whether or not to allow continued competitive sport participation. One option is to discontinue training and serially measure these variables.<ce:cross-refs refid="bib27 bib48 bib62"><ce:sup>27,48,62</ce:sup></ce:cross-refs> Normalization would suggest physiologic change and an athlete might be allowed to resume competitive sport participation.<ce:cross-refs refid="bib42 bib48 bib62"><ce:sup>42,48,62</ce:sup></ce:cross-refs></ce:para><ce:para>Several changes are noted on an ECG due to cardiac remodeling with regular exercise training. Approximately 60% of athletes have a normal ECG whereas 15% may have ECG changes suggestive of an underlying heart disease.<ce:cross-refs refid="bib44 bib47 bib48"><ce:sup>44,47,48</ce:sup></ce:cross-refs> The most commonly observed ECG changes in athletes include early repolarization, increased QRS voltages, diffuse T-wave inversion, and deep Q waves.<ce:cross-refs refid="bib44 bib47"><ce:sup>44,47</ce:sup></ce:cross-refs> The most common rhythm abnormalities in athletes include bradycardia, first-degree heart block, and Wenckebach phenomenon.<ce:cross-refs refid="bib44 bib47"><ce:sup>44,47</ce:sup></ce:cross-refs> Recent studies with Holter monitor have identified more complex ventricular arrhythmias, which are usually abolished on discontinuing training and may be of no clinical significance. These may be considered part of the spectrum that constitutes an athlete&apos;s heart.<ce:cross-refs refid="bib44 bib47"><ce:sup>44,47</ce:sup></ce:cross-refs></ce:para><ce:para>In most athletes, the changes in the heart that occur with regular training and conditioning regress with deconditioning; however, in 20% of these athletes, the changes may be permanent.<ce:cross-refs refid="bib1 bib47"><ce:sup>1,47</ce:sup></ce:cross-refs> There is no evidence to show that the cardiac remodeling in an athlete has a disabling, permanent, or detrimental course.<ce:cross-ref refid="bib47"><ce:sup>47</ce:sup></ce:cross-ref></ce:para></ce:section></ce:section><ce:section id="sec3.3"><ce:section-title>2-D ECHO</ce:section-title><ce:para>2-D ECHO is most useful for the diagnosis of structural heart disease.<ce:cross-refs refid="bib45 bib63"><ce:sup>45,63</ce:sup></ce:cross-refs> Diastolic and systolic function, wall motion abnormalities, wall thickness, valve morphology, and internal chamber size can be assessed with confidence with ECHO. ECHO has also been shown to be useful in visualizing the origin of the coronary arteries.<ce:cross-refs refid="bib64 bib65"><ce:sup>64,65</ce:sup></ce:cross-refs> Including contrast and tissue Doppler greatly increases the likelihood of diagnosing ARVC while using the ECHO.<ce:cross-refs refid="bib63 bib64"><ce:sup>63,64</ce:sup></ce:cross-refs> Adding an ECHO to a cardiovascular screening program increases the likelihood of identifying structural abnormalities of the heart. The added cost of screening and the scarcity of resources, equipment, and personnel are significant barriers to recommend routine use of ECHO for screening. An ECHO can be considered a good confirmatory test after abnormal findings on H&amp;P or ECG.</ce:para></ce:section><ce:section id="sec3.4"><ce:section-title>Genetic Testing</ce:section-title><ce:para>There have been significant advances in the identification of genetic causes for cardiovascular diseases,<ce:cross-refs refid="bib66 bib67 bib68 bib69"><ce:sup>66&ndash;69</ce:sup></ce:cross-refs> leading to the question of present or future methods involving identification of genetic risk factors for cardiovascular disease using genetic testing as a screening tool. Even though progress has been made in identification of these genetic mutations, the genotype-phenotype correlation is still poor. It cannot be reliably predicted if an identified mutation will eventually lead to an expression of disease. This may lead to a high false-positive rate. With more mutations identified, the battery of tests is ever-increasing and to apply the entire set to an athlete is not prudent, which leads back to the need for a good H&amp;P as an initial screening tool with emphasis on family history to identify individuals at risk. Once a proband is identified, an entire family can be screened for that specific mutation that has been identified.<ce:cross-refs refid="bib64 bib68"><ce:sup>64,68</ce:sup></ce:cross-refs></ce:para></ce:section><ce:section id="sec3.5"><ce:section-title>Other Tests</ce:section-title><ce:para>Exercise stress testing is of limited value as a screening tool but has a role in risk stratification.<ce:cross-ref refid="bib45"><ce:sup>45</ce:sup></ce:cross-ref> Exercise stress testing has been recommended in athletes older than 35. This is also part of the extended Italian recommendation for athletes older than 35.<ce:cross-ref refid="bib2"><ce:sup>2</ce:sup></ce:cross-ref> Maximal exercise testing is an integral component to unmask arrhythmia in ARVC, familial catecholaminergic polymorphic ventricular tachycardia, and long QT syndrome. Frequent ventricular extrasystoles during exercise indicate underlying cardiac disease.<ce:cross-ref refid="bib45"><ce:sup>45</ce:sup></ce:cross-ref></ce:para><ce:para>Several other tests are available for identification of certain specific conditions.<ce:cross-refs refid="bib45 bib70"><ce:sup>45,70</ce:sup></ce:cross-refs> These include Holter monitoring (quantification of extrasystoles and identification of tachy- and bradyarrythmias), cardiac MRI scan (ARVC, HCM, and myocarditis), tissue Doppler (ARVC), sodium channel blocker challenge (Brugada syndrome), and adenosine challenge for pre-excitation (familial risk of WPW syndrome and supraventricular tachycardia). These tests are not appropriate for mass screening due to low yield and also due to the need for expertise to successfully obtain and interpret the results. They become important after screening has raised concerns for specific problems.</ce:para></ce:section></ce:section><ce:section id="sec4"><ce:section-title>Summary</ce:section-title><ce:para>Identification of young athletes at risk for an adverse cardiovascular event during sport participation is a challenging task. Even in the best of circumstances, outcome of SCA on the field remains poor; therefore, prevention is critical. Cardiovascular screening of young athletes is based on ascertaining specific history and a thorough physical examination. Although inclusion of an ECG in screening asymptomatic athletes has been shown to increase the likelihood of identifying athletes at risk, considerable logistical and economic challenges remain, including using ECG as a screening tool. Even the most ideal screening strategy may not identify all athletes at risk for SCA on the field, and unfortunately SCD may be the first clinical manifestation of some cardiac conditions.</ce:para></ce:section></ce:sections><ce:acknowledgment><ce:section-title>Acknowledgments</ce:section-title><ce:para>Parts of this article are updated and adapted from authors' previous work, Siddiqui SA, Patel DR. Prevention of sudden cardiac death in young athletes: impact and limitations of preparticipation screening. International Public Health Journal 2009;1(4):379--88, with permission.</ce:para></ce:acknowledgment></body><tail><ce:bibliography><ce:section-title>References</ce:section-title><ce:bibliography-sec><ce:bib-reference id="bib1"><ce:label>1</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>B.J.</ce:given-name><ce:surname>Maron</ce:surname></sb:author><sb:author><ce:given-name>P.D.</ce:given-name><ce:surname>Thompson</ce:surname></sb:author><sb:author><ce:given-name>M.J.</ce:given-name><ce:surname>Ackerman</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Circulation</sb:maintitle></sb:title><sb:volume-nr>115</sb:volume-nr></sb:series><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>1643</sb:first-page><sb:last-page>1655</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib2"><ce:label>2</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Corrado</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Pelliccia</ce:surname></sb:author><sb:author><ce:given-name>H.H.</ce:given-name><ce:surname>Bjornstad</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Eur Heart J</sb:maintitle></sb:title><sb:volume-nr>26</sb:volume-nr></sb:series><sb:date>2005</sb:date></sb:issue><sb:pages><sb:first-page>516</sb:first-page><sb:last-page>524</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib3"><ce:label>3</ce:label><sb:reference><sb:contribution><sb:title><sb:maintitle>American College of Cardiology 36th Bethesda Conference: eligibility recommendations for competitive athletes with cardiovascular abnormalities</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J&nbsp;Am Coll Cardiol</sb:maintitle></sb:title><sb:volume-nr>45</sb:volume-nr></sb:series><sb:issue-nr>8</sb:issue-nr><sb:date>2005</sb:date></sb:issue><sb:pages><sb:first-page>1317</sb:first-page><sb:last-page>1375</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib4"><ce:label>4</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Berger</ce:surname></sb:author><sb:author><ce:given-name>J.D.</ce:given-name><ce:surname>Kugler</ce:surname></sb:author><sb:author><ce:given-name>J.A.</ce:given-name><ce:surname>Thomas</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Sudden cardiac death in children and adolescents: introduction and overview</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Pediatr Clin North Am</sb:maintitle></sb:title><sb:volume-nr>51</sb:volume-nr></sb:series><sb:issue-nr>5</sb:issue-nr><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>1201</sb:first-page><sb:last-page>1209</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib5"><ce:label>5</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>B.J.</ce:given-name><ce:surname>Maron</ce:surname></sb:author><sb:author><ce:given-name>J.J.</ce:given-name><ce:surname>Doerer</ce:surname></sb:author><sb:author><ce:given-name>T.S.</ce:given-name><ce:surname>Haas</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Sudden deaths in young athletes: analysis of 1866 death in the United States, 1980&ndash;2006</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Circulation</sb:maintitle></sb:title><sb:volume-nr>119</sb:volume-nr></sb:series><sb:date>2009</sb:date></sb:issue><sb:pages><sb:first-page>1085</sb:first-page><sb:last-page>1092</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib6"><ce:label>6</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>B.J.</ce:given-name><ce:surname>Maron</ce:surname></sb:author><sb:author><ce:given-name>T.S.</ce:given-name><ce:surname>Haas</ce:surname></sb:author><sb:author><ce:given-name>J.J.</ce:given-name><ce:surname>Doerer</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Comparison of US and Italian experiences with sudden cardiac deaths in young competitive athletes and implications for preparticipation screening strategies</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Am J Cardiol</sb:maintitle></sb:title><sb:volume-nr>104</sb:volume-nr></sb:series><sb:date>2009</sb:date></sb:issue><sb:pages><sb:first-page>276</sb:first-page><sb:last-page>280</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib7"><ce:label>7</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>J.A.</ce:given-name><ce:surname>Drezner</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Preparing for sudden cardiac arrest&mdash;the essential role of automated external defibrillators in athletic medicine: a critical review</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Br J Sports Med</sb:maintitle></sb:title><sb:volume-nr>43</sb:volume-nr></sb:series><sb:date>2009</sb:date></sb:issue><sb:pages><sb:first-page>702</sb:first-page><sb:last-page>707</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib8"><ce:label>8</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>C.A.</ce:given-name><ce:surname>Germann</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Sudden cardiac death in athletes: a guide for emergency physicians</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Am J Emerg Med</sb:maintitle></sb:title><sb:volume-nr>23</sb:volume-nr></sb:series><sb:date>2005</sb:date></sb:issue><sb:pages><sb:first-page>504</sb:first-page><sb:last-page>509</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib9"><ce:label>9</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>J.A.</ce:given-name><ce:surname>Drezner</ce:surname></sb:author><sb:author><ce:given-name>R.W.</ce:given-name><ce:surname>Courson</ce:surname></sb:author><sb:author><ce:given-name>W.O.</ce:given-name><ce:surname>Roberts</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Inter-association task force recommendations on emergency preparedness and management of sudden cardiac arrest in high school and college athletic programs: a consensus statement</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J&nbsp;Athl Train</sb:maintitle></sb:title><sb:volume-nr>42</sb:volume-nr></sb:series><sb:issue-nr>1</sb:issue-nr><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>143</sb:first-page><sb:last-page>158</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib10"><ce:label>10</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>B.J.</ce:given-name><ce:surname>Maron</ce:surname></sb:author><sb:author><ce:given-name>T.F.</ce:given-name><ce:surname>Gohman</ce:surname></sb:author><sb:author><ce:given-name>S.B.</ce:given-name><ce:surname>Kyle</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Clinical profile and spectrum of Commtio Cordis</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>JAMA</sb:maintitle></sb:title><sb:volume-nr>287</sb:volume-nr></sb:series><sb:date>2002</sb:date></sb:issue><sb:pages><sb:first-page>1142</sb:first-page><sb:last-page>1146</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib11"><ce:label>11</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>B.J.</ce:given-name><ce:surname>Maron</ce:surname></sb:author><sb:author><ce:given-name>D.C.</ce:given-name><ce:surname>Wentzel</ce:surname></sb:author><sb:author><ce:given-name>A.G.</ce:given-name><ce:surname>Zenovich</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Death in a young athlete due to commotio cordis despite prompt external defibrillation</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Heart Rhythm</sb:maintitle></sb:title><sb:volume-nr>2</sb:volume-nr></sb:series><sb:date>2005</sb:date></sb:issue><sb:pages><sb:first-page>991</sb:first-page><sb:last-page>993</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib12"><ce:label>12</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>R.J.</ce:given-name><ce:surname>Myerburg</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Sudden cardiac death: exploring the limits of our knowledge</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J&nbsp;Cardiovasc Electrophysiol</sb:maintitle></sb:title><sb:volume-nr>12</sb:volume-nr></sb:series><sb:date>2001</sb:date></sb:issue><sb:pages><sb:first-page>369</sb:first-page><sb:last-page>381</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib13"><ce:label>13</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>K.G.</ce:given-name><ce:surname>Harmon</ce:surname></sb:author><sb:author><ce:given-name>J.A.</ce:given-name><ce:surname>Drezner</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Update on sideline and event preparation for management of sudden cardiac arrest in athletes</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Curr Sports Med Rep</sb:maintitle></sb:title><sb:volume-nr>6</sb:volume-nr></sb:series><sb:issue-nr>3</sb:issue-nr><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>170</sb:first-page><sb:last-page>176</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib14"><ce:label>14</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>F.C.</ce:given-name><ce:surname>Basilico</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Cardiovascular disease in athletes</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Am J Sports Med</sb:maintitle></sb:title><sb:volume-nr>27</sb:volume-nr></sb:series><sb:date>1999</sb:date></sb:issue><sb:pages><sb:first-page>108</sb:first-page><sb:last-page>121</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib15"><ce:label>15</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>R.C.</ce:given-name><ce:surname>Cantu</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Congenital cardiovascular disease: the major cause of athletic death in high school and college</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Med Sci Sports Exerc</sb:maintitle></sb:title><sb:volume-nr>24</sb:volume-nr></sb:series><sb:date>1992</sb:date></sb:issue><sb:pages><sb:first-page>279</sb:first-page><sb:last-page>280</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib16"><ce:label>16</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>B.J.</ce:given-name><ce:surname>Maron</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Shirani</ce:surname></sb:author><sb:author><ce:given-name>L.C.</ce:given-name><ce:surname>Poliac</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Sudden death in young competitive athletes: clinical, demographic, and pathological profiles</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>JAMA</sb:maintitle></sb:title><sb:volume-nr>276</sb:volume-nr></sb:series><sb:date>1996</sb:date></sb:issue><sb:pages><sb:first-page>199</sb:first-page><sb:last-page>204</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib17"><ce:label>17</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>B.J.</ce:given-name><ce:surname>Maron</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Sudden death in young athletes</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>N&nbsp;Engl J Med</sb:maintitle></sb:title><sb:volume-nr>349</sb:volume-nr></sb:series><sb:date>2003</sb:date></sb:issue><sb:pages><sb:first-page>1064</sb:first-page><sb:last-page>1075</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib18"><ce:label>18</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Corrado</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Basso</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Schiavon</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Pre-participation screening of young competitive athletes for prevention of sudden cardiac death</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J&nbsp;Am Coll Cardiol</sb:maintitle></sb:title><sb:volume-nr>52</sb:volume-nr></sb:series><sb:issue-nr>24</sb:issue-nr><sb:date>2008</sb:date></sb:issue><sb:pages><sb:first-page>1981</sb:first-page><sb:last-page>1989</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib19"><ce:label>19</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>P.D.</ce:given-name><ce:surname>Thompson</ce:surname></sb:author><sb:author><ce:given-name>B.D.</ce:given-name><ce:surname>Levine</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Protecting athletes from sudden cardiac death</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>JAMA</sb:maintitle></sb:title><sb:volume-nr>296</sb:volume-nr></sb:series><sb:issue-nr>13</sb:issue-nr><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>1648</sb:first-page><sb:last-page>1650</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib20"><ce:label>20</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Corrado</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Basso</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Pavei</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>JAMA</sb:maintitle></sb:title><sb:volume-nr>296</sb:volume-nr></sb:series><sb:issue-nr>13</sb:issue-nr><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>1593</sb:first-page><sb:last-page>1601</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib21"><ce:label>21</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Bille</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Figueiras</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Schamasch</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Position paper: sudden cardiac death in athletes: the Lausanne recommendations</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Eur J Cardiovasc Prev Rehabil</sb:maintitle></sb:title><sb:volume-nr>13</sb:volume-nr></sb:series><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>859</sb:first-page><sb:last-page>875</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib22"><ce:label>22</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>B.J.</ce:given-name><ce:surname>Maron</ce:surname></sb:author><sb:author><ce:given-name>T.C.</ce:given-name><ce:surname>Gohman</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Aeppli</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Prevalence of sudden cardiac death during competitive sports activities in Minnesota high school athletes</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J&nbsp;Am Coll Cardiol</sb:maintitle></sb:title><sb:volume-nr>32</sb:volume-nr></sb:series><sb:date>1998</sb:date></sb:issue><sb:pages><sb:first-page>1881</sb:first-page><sb:last-page>1884</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib23"><ce:label>23</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>B.J.</ce:given-name><ce:surname>Maron</ce:surname></sb:author><sb:author><ce:given-name>K.P.</ce:given-name><ce:surname>Carney</ce:surname></sb:author><sb:author><ce:given-name>H.M.</ce:given-name><ce:surname>Lever</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J&nbsp;Am Coll Cardiol</sb:maintitle></sb:title><sb:volume-nr>41</sb:volume-nr></sb:series><sb:date>2003</sb:date></sb:issue><sb:pages><sb:first-page>974</sb:first-page><sb:last-page>980</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib24"><ce:label>24</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>S.P.</ce:given-name><ce:surname>Van Camp</ce:surname></sb:author><sb:author><ce:given-name>C.M.</ce:given-name><ce:surname>Bloor</ce:surname></sb:author><sb:author><ce:given-name>F.O.</ce:given-name><ce:surname>Mueller</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Non-traumatic sports death in high schools and college athletes</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Med Sci Sports Exerc</sb:maintitle></sb:title><sb:volume-nr>27</sb:volume-nr></sb:series><sb:date>1995</sb:date></sb:issue><sb:pages><sb:first-page>641</sb:first-page><sb:last-page>647</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib25"><ce:label>25</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Corrado</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Basso</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Rizzoli</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Does sports activity enhance the risk of sudden death in adolescents and young adults?</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J&nbsp;Am Coll Cardiol</sb:maintitle></sb:title><sb:volume-nr>42</sb:volume-nr></sb:series><sb:issue-nr>11</sb:issue-nr><sb:date>2003</sb:date></sb:issue><sb:pages><sb:first-page>1959</sb:first-page><sb:last-page>1963</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib26"><ce:label>26</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>B.J.</ce:given-name><ce:surname>Maron</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Triggers for sudden cardiac death in athlete</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cardiol Clin</sb:maintitle></sb:title><sb:volume-nr>14</sb:volume-nr></sb:series><sb:date>1996</sb:date></sb:issue><sb:pages><sb:first-page>195</sb:first-page><sb:last-page>210</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib27"><ce:label>27</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>B.J.</ce:given-name><ce:surname>Maron</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Pelliccia</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Spirito</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Cardiac disease in young trained athletes. Insights into methods for distinguishing athlete&apos;s heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Circulation</sb:maintitle></sb:title><sb:volume-nr>91</sb:volume-nr></sb:series><sb:issue-nr>5</sb:issue-nr><sb:date>1995</sb:date></sb:issue><sb:pages><sb:first-page>1596</sb:first-page><sb:last-page>1601</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib28"><ce:label>28</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Corrado</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Basso</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Schiavon</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Screening for hypertrophic cardiomyopathy in young athletes</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>N&nbsp;Engl J Med</sb:maintitle></sb:title><sb:volume-nr>339</sb:volume-nr></sb:series><sb:issue-nr>6</sb:issue-nr><sb:date>1998</sb:date></sb:issue><sb:pages><sb:first-page>364</sb:first-page><sb:last-page>369</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib29"><ce:label>29</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>M.S.</ce:given-name><ce:surname>Maron</ce:surname></sb:author><sb:author><ce:given-name>I.</ce:given-name><ce:surname>Olivotto</ce:surname></sb:author><sb:author><ce:given-name>A.G.</ce:given-name><ce:surname>Zenovich</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Circulation</sb:maintitle></sb:title><sb:volume-nr>114</sb:volume-nr></sb:series><sb:issue-nr>21</sb:issue-nr><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>2232</sb:first-page><sb:last-page>2239</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib30"><ce:label>30</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>B.J.</ce:given-name><ce:surname>Maron</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Hypertrophic cardiomyopathy: a systematic review</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>JAMA</sb:maintitle></sb:title><sb:volume-nr>287</sb:volume-nr></sb:series><sb:issue-nr>10</sb:issue-nr><sb:date>2002</sb:date></sb:issue><sb:pages><sb:first-page>1308</sb:first-page><sb:last-page>1320</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib31"><ce:label>31</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>B.J.</ce:given-name><ce:surname>Maron</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Hypertrophic cardiomyopathy</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Curr Probl Cardiol</sb:maintitle></sb:title><sb:volume-nr>18</sb:volume-nr></sb:series><sb:date>1993</sb:date></sb:issue><sb:pages><sb:first-page>639</sb:first-page><sb:last-page>704</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib32"><ce:label>32</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Basso</ce:surname></sb:author><sb:author><ce:given-name>B.J.</ce:given-name><ce:surname>Maron</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Corrado</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Clinical profile of congenital coronary artery anomalies with origin from the wrong aortic sinus leading to sudden death in young competitive athletes</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J&nbsp;Am Coll Cardiol</sb:maintitle></sb:title><sb:volume-nr>35</sb:volume-nr></sb:series><sb:date>2000</sb:date></sb:issue><sb:pages><sb:first-page>1493</sb:first-page><sb:last-page>1501</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib33"><ce:label>33</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>M.S.</ce:given-name><ce:surname>Link</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Wang</ce:surname></sb:author><sb:author><ce:given-name>N.G.</ce:given-name><ce:surname>Pandian</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>An experimental model of sudden death due to low-energy chest-wall impact (commotio cordis)</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>N&nbsp;Engl J Med</sb:maintitle></sb:title><sb:volume-nr>338</sb:volume-nr></sb:series><sb:date>1998</sb:date></sb:issue><sb:pages><sb:first-page>1805</sb:first-page><sb:last-page>1811</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib34"><ce:label>34</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>D.W.</ce:given-name><ce:surname>Glover</ce:surname></sb:author><sb:author><ce:given-name>B.J.</ce:given-name><ce:surname>Maron</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Profile of preparticipation cardiovascular screening for high school athletes</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>JAMA</sb:maintitle></sb:title><sb:volume-nr>279</sb:volume-nr></sb:series><sb:issue-nr>22</sb:issue-nr><sb:date>1998</sb:date></sb:issue><sb:pages><sb:first-page>1817</sb:first-page><sb:last-page>1819</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib35"><ce:label>35</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>D.W.</ce:given-name><ce:surname>Glover</ce:surname></sb:author><sb:author><ce:given-name>B.J.</ce:given-name><ce:surname>Maron</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Evolution over 8 years of the US preparticipation screening process for undetected cardiovascular disease in US high school athletes</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Circulation</sb:maintitle></sb:title><sb:volume-nr>114</sb:volume-nr></sb:series><sb:issue-nr>Suppl II</sb:issue-nr><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>II502</sb:first-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib36"><ce:label>36</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>G.C.</ce:given-name><ce:surname>Pfister</ce:surname></sb:author><sb:author><ce:given-name>J.C.</ce:given-name><ce:surname>Puffer</ce:surname></sb:author><sb:author><ce:given-name>B.J.</ce:given-name><ce:surname>Maron</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Preparticipation cardiovascular screening for US collegiate student-athletes</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>JAMA</sb:maintitle></sb:title><sb:volume-nr>283</sb:volume-nr></sb:series><sb:issue-nr>12</sb:issue-nr><sb:date>2000</sb:date></sb:issue><sb:pages><sb:first-page>1597</sb:first-page><sb:last-page>1599</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib37"><ce:label>37</ce:label><sb:reference><sb:contribution><sb:title><sb:maintitle>Preparticipation physical evaluation</sb:maintitle></sb:title></sb:contribution><sb:host><sb:book><sb:edition>3rd edition</sb:edition><sb:date>2005</sb:date><sb:publisher><sb:name>McGraw-Hill/The Physican and Sports Medicine</sb:name><sb:location>Minneapolis (MN)</sb:location></sb:publisher></sb:book></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib38"><ce:label>38</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>C.M.</ce:given-name><ce:surname>Fuller</ce:surname></sb:author><sb:author><ce:given-name>C.M.</ce:given-name><ce:surname>McNulty</ce:surname></sb:author><sb:author><ce:given-name>D.A.</ce:given-name><ce:surname>Spring</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Prospective screening of 5,615 high school athletes for risk of sudden cardiac death</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Med Sci Sports Exerc</sb:maintitle></sb:title><sb:volume-nr>29</sb:volume-nr></sb:series><sb:date>1997</sb:date></sb:issue><sb:pages><sb:first-page>1131</sb:first-page><sb:last-page>1138</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib39"><ce:label>39</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Corrado</ce:surname></sb:author><sb:author><ce:given-name>W.J.</ce:given-name><ce:surname>McKenna</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Appropriate interpretation of the athlete&apos;s electrocardiogram saves lives as well as money</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Eur Heart J</sb:maintitle></sb:title><sb:volume-nr>28</sb:volume-nr></sb:series><sb:issue-nr>16</sb:issue-nr><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>1920</sb:first-page><sb:last-page>1922</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib40"><ce:label>40</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Tasaki</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Hamasaki</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Ichimaru</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Mass screening for heart disease of school children in Saga city: 7-year follow up study</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Jpn Circ J</sb:maintitle></sb:title><sb:volume-nr>51</sb:volume-nr></sb:series><sb:date>1987</sb:date></sb:issue><sb:pages><sb:first-page>1415</sb:first-page><sb:last-page>1420</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib41"><ce:label>41</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>R.J.</ce:given-name><ce:surname>Myerburg</ce:surname></sb:author><sb:author><ce:given-name>V.L.</ce:given-name><ce:surname>Vetter</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Electrocardiograms should be included in preparticipation screening of athletes</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Circulation</sb:maintitle></sb:title><sb:volume-nr>116</sb:volume-nr></sb:series><sb:issue-nr>22</sb:issue-nr><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>2616</sb:first-page><sb:last-page>2626</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib42"><ce:label>42</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Pelliccia</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Culasso</ce:surname></sb:author><sb:author><ce:given-name>F.M.</ce:given-name><ce:surname>Di Paolo</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Prevalence of abnormal electrocardiograms in a large, unselected population undergoing pre-participation cardiovascular screening</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Eur Heart J</sb:maintitle></sb:title><sb:volume-nr>28</sb:volume-nr></sb:series><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>2006</sb:first-page><sb:last-page>2010</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib43"><ce:label>43</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Tanaka</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Yoshinaga</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Anan</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Usefulness and cost effectiveness of cardiovascular screening of young adolescents</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Med Sci Sports Exerc</sb:maintitle></sb:title><sb:volume-nr>38</sb:volume-nr></sb:series><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>2</sb:first-page><sb:last-page>6</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib44"><ce:label>44</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Corrado</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Pelliccia</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Heidbuchel</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Recommendations for interpretation of 12-lead electrocardiogram in the athlete</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Eur Heart J</sb:maintitle></sb:title><sb:volume-nr>31</sb:volume-nr></sb:series><sb:issue-nr>2</sb:issue-nr><sb:date>2010</sb:date></sb:issue><sb:pages><sb:first-page>243</sb:first-page><sb:last-page>259</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib45"><ce:label>45</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Attari</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Dhala</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Role of invasive and noninvasive testing in risk stratification of sudden cardiac death in children and young adults: an electrophysiologic perspective</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Pediatr Clin North Am</sb:maintitle></sb:title><sb:volume-nr>51</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>1355</sb:first-page><sb:last-page>1378</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib46"><ce:label>46</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Sen-choudary</ce:surname></sb:author><sb:author><ce:given-name>W.J.</ce:given-name><ce:surname>McKenna</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Sudden cardiac death in the young: a strategy for prevention by targeted evaluation</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cardiology</sb:maintitle></sb:title><sb:volume-nr>105</sb:volume-nr></sb:series><sb:issue-nr>4</sb:issue-nr><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>196</sb:first-page><sb:last-page>206</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib47"><ce:label>47</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>B.J.</ce:given-name><ce:surname>Maron</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Pelliccia</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The heart of trained athletes: cardiac remodeling and the risk of sports, including sudden death</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Circulation</sb:maintitle></sb:title><sb:volume-nr>114</sb:volume-nr></sb:series><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>1633</sb:first-page><sb:last-page>1644</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib48"><ce:label>48</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>W.B.</ce:given-name><ce:surname>Abernethy</ce:surname></sb:author><sb:author><ce:given-name>J.K.</ce:given-name><ce:surname>Choo</ce:surname></sb:author><sb:author><ce:given-name>A.M.</ce:given-name><ce:surname>Hutter</ce:surname><ce:suffix>Jr.</ce:suffix></sb:author></sb:authors><sb:title><sb:maintitle>Echocardiographic characteristics of professional football players</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J&nbsp;Am Coll Cardiol</sb:maintitle></sb:title><sb:volume-nr>41</sb:volume-nr></sb:series><sb:issue-nr>2</sb:issue-nr><sb:date>2003</sb:date></sb:issue><sb:pages><sb:first-page>280</sb:first-page><sb:last-page>284</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib49"><ce:label>49</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Fagard</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Athlete&apos;s heart</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Heart</sb:maintitle></sb:title><sb:volume-nr>89</sb:volume-nr></sb:series><sb:issue-nr>12</sb:issue-nr><sb:date>2003</sb:date></sb:issue><sb:pages><sb:first-page>1455</sb:first-page><sb:last-page>1461</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib50"><ce:label>50</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Quaglini</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Rognoni</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Spazzolini</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Cost-effectiveness of neonatal ECG screening for the long QT syndrome</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Eur Heart J</sb:maintitle></sb:title><sb:volume-nr>27</sb:volume-nr></sb:series><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>1824</sb:first-page><sb:last-page>1832</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib51"><ce:label>51</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Rost</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The athlete&apos;s heart: historical perspective</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cardiol Clin</sb:maintitle></sb:title><sb:volume-nr>10</sb:volume-nr></sb:series><sb:issue-nr>2</sb:issue-nr><sb:date>1992</sb:date></sb:issue><sb:pages><sb:first-page>197</sb:first-page><sb:last-page>207</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib52"><ce:label>52</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Spirito</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Pelliccia</ce:surname></sb:author><sb:author><ce:given-name>M.A.</ce:given-name><ce:surname>Proschan</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Morphology of the &ldquo;athlete&apos;s heart&rdquo; assessed by echocardiography in 947 elite athletes representing 27 sports</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Am J Cardiol</sb:maintitle></sb:title><sb:volume-nr>74</sb:volume-nr></sb:series><sb:issue-nr>8</sb:issue-nr><sb:date>1994</sb:date></sb:issue><sb:pages><sb:first-page>802</sb:first-page><sb:last-page>806</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib53"><ce:label>53</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Pelliccia</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Culasso</ce:surname></sb:author><sb:author><ce:given-name>F.M.</ce:given-name><ce:surname>Di Paolo</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Physiologic left ventricular cavity dilatation in elite athletes</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Ann Intern Med</sb:maintitle></sb:title><sb:volume-nr>130</sb:volume-nr></sb:series><sb:issue-nr>1</sb:issue-nr><sb:date>1999</sb:date></sb:issue><sb:pages><sb:first-page>23</sb:first-page><sb:last-page>31</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib54"><ce:label>54</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Pelliccia</ce:surname></sb:author><sb:author><ce:given-name>B.J.</ce:given-name><ce:surname>Maron</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Culasso</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Clinical significance of abnormal electrocardiographic patterns in trained athletes</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Circulation</sb:maintitle></sb:title><sb:volume-nr>102</sb:volume-nr></sb:series><sb:issue-nr>3</sb:issue-nr><sb:date>2000</sb:date></sb:issue><sb:pages><sb:first-page>278</sb:first-page><sb:last-page>284</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib55"><ce:label>55</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>T.P.</ce:given-name><ce:surname>Huston</ce:surname></sb:author><sb:author><ce:given-name>J.C.</ce:given-name><ce:surname>Puffer</ce:surname></sb:author><sb:author><ce:given-name>W.M.</ce:given-name><ce:surname>Rodney</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The athletic heart syndrome</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>N&nbsp;Engl J Med</sb:maintitle></sb:title><sb:volume-nr>313</sb:volume-nr></sb:series><sb:issue-nr>1</sb:issue-nr><sb:date>1985</sb:date></sb:issue><sb:pages><sb:first-page>24</sb:first-page><sb:last-page>32</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib56"><ce:label>56</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>J.K.</ce:given-name><ce:surname>Choo</ce:surname></sb:author><sb:author><ce:given-name>W.B.</ce:given-name><ce:surname>Abernethy</ce:surname><ce:suffix>3rd</ce:suffix></sb:author><sb:author><ce:given-name>A.M.</ce:given-name><ce:surname>Hutter</ce:surname><ce:suffix>Jr.</ce:suffix></sb:author></sb:authors><sb:title><sb:maintitle>Electrocardiographic observations in professional football players</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Am J Cardiol</sb:maintitle></sb:title><sb:volume-nr>90</sb:volume-nr></sb:series><sb:issue-nr>2</sb:issue-nr><sb:date>2002</sb:date></sb:issue><sb:pages><sb:first-page>198</sb:first-page><sb:last-page>200</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib57"><ce:label>57</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>G.J.</ce:given-name><ce:surname>Balady</ce:surname></sb:author><sb:author><ce:given-name>J.B.</ce:given-name><ce:surname>Cadigan</ce:surname></sb:author><sb:author><ce:given-name>T.J.</ce:given-name><ce:surname>Ryan</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Electrocardiogram of the athlete: an analysis of 289 professional football players</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Am J Cardiol</sb:maintitle></sb:title><sb:volume-nr>53</sb:volume-nr></sb:series><sb:issue-nr>9</sb:issue-nr><sb:date>1984</sb:date></sb:issue><sb:pages><sb:first-page>1339</sb:first-page><sb:last-page>1343</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib58"><ce:label>58</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Biffi</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Pelliccia</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Verdile</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J&nbsp;Am Coll Cardiol</sb:maintitle></sb:title><sb:volume-nr>40</sb:volume-nr></sb:series><sb:issue-nr>3</sb:issue-nr><sb:date>2002</sb:date></sb:issue><sb:pages><sb:first-page>446</sb:first-page><sb:last-page>452</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib59"><ce:label>59</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Biffi</ce:surname></sb:author><sb:author><ce:given-name>B.J.</ce:given-name><ce:surname>Maron</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Verdile</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Impact of physical deconditioning on ventricular tachyarrhythmias in trained athletes</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J&nbsp;Am Coll Cardiol</sb:maintitle></sb:title><sb:volume-nr>44</sb:volume-nr></sb:series><sb:issue-nr>5</sb:issue-nr><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>1053</sb:first-page><sb:last-page>1058</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib60"><ce:label>60</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Pelliccia</ce:surname></sb:author><sb:author><ce:given-name>B.J.</ce:given-name><ce:surname>Maron</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Culasso</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Athlete&apos;s heart in women. Echocardiographic characterization of highly trained elite female athletes</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>JAMA</sb:maintitle></sb:title><sb:volume-nr>276</sb:volume-nr></sb:series><sb:issue-nr>3</sb:issue-nr><sb:date>1996</sb:date></sb:issue><sb:pages><sb:first-page>211</sb:first-page><sb:last-page>215</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib61"><ce:label>61</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Sharma</ce:surname></sb:author><sb:author><ce:given-name>B.J.</ce:given-name><ce:surname>Maron</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Whyte</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Physiologic limits of left ventricular hypertrophy in elite junior athletes: relevance to differential diagnosis of athlete&apos;s heart and hypertrophic cardiomyopathy</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J&nbsp;Am Coll Cardiol</sb:maintitle></sb:title><sb:volume-nr>40</sb:volume-nr></sb:series><sb:issue-nr>8</sb:issue-nr><sb:date>2002</sb:date></sb:issue><sb:pages><sb:first-page>1431</sb:first-page><sb:last-page>1436</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib62"><ce:label>62</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Pelliccia</ce:surname></sb:author><sb:author><ce:given-name>B.J.</ce:given-name><ce:surname>Maron</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>De Luca</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Remodeling of left ventricular hypertrophy in elite athletes after long-term deconditioning</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Circulation</sb:maintitle></sb:title><sb:volume-nr>105</sb:volume-nr></sb:series><sb:issue-nr>8</sb:issue-nr><sb:date>2002</sb:date></sb:issue><sb:pages><sb:first-page>944</sb:first-page><sb:last-page>949</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib63"><ce:label>63</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>J.R.</ce:given-name><ce:surname>Cava</ce:surname></sb:author><sb:author><ce:given-name>M.J.</ce:given-name><ce:surname>Danduran</ce:surname></sb:author><sb:author><ce:given-name>R.T.</ce:given-name><ce:surname>Fedderly</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Exercise recommendations and risk factors for sudden cardiac death</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Pediatr Clin North Am</sb:maintitle></sb:title><sb:volume-nr>51</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>1401</sb:first-page><sb:last-page>1420</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib64"><ce:label>64</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Zeppilli</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>dello Russo</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Santini</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>In vivo detection of coronary artery anomalies in asymptomatic athletes by echocardiographic screening</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Chest</sb:maintitle></sb:title><sb:volume-nr>114</sb:volume-nr></sb:series><sb:date>1998</sb:date></sb:issue><sb:pages><sb:first-page>89</sb:first-page><sb:last-page>93</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib65"><ce:label>65</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>K.A.</ce:given-name><ce:surname>Crispell</ce:surname></sb:author><sb:author><ce:given-name>E.L.</ce:given-name><ce:surname>Hanson</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Coates</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Periodic rescreening is indicated for family members at risk of developing familial dilated cardiomyopathy</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J&nbsp;Am Coll Cardiol</sb:maintitle></sb:title><sb:volume-nr>39</sb:volume-nr></sb:series><sb:date>2002</sb:date></sb:issue><sb:pages><sb:first-page>1503</sb:first-page><sb:last-page>1507</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib66"><ce:label>66</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Brugada</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Hong</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Dumaine</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Sudden death associated with short-QTsyndrome linked to mutations in HERG</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Circulation</sb:maintitle></sb:title><sb:volume-nr>109</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>30</sb:first-page><sb:last-page>35</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib67"><ce:label>67</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Schimpf</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Wolpert</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Gaita</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Short QT syndrome</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cardiovasc Res</sb:maintitle></sb:title><sb:volume-nr>67</sb:volume-nr></sb:series><sb:date>2005</sb:date></sb:issue><sb:pages><sb:first-page>357</sb:first-page><sb:last-page>366</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib68"><ce:label>68</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Tan</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Hofman</ce:surname></sb:author><sb:author><ce:given-name>I.</ce:given-name><ce:surname>van Langen</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Sudden unexplained death: heritability and diagnostic yield of cardiological and genetic examination in surviving relatives</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Circulation</sb:maintitle></sb:title><sb:volume-nr>112</sb:volume-nr></sb:series><sb:date>2005</sb:date></sb:issue><sb:pages><sb:first-page>207</sb:first-page><sb:last-page>213</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib69"><ce:label>69</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Tester</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Kopplin</ce:surname></sb:author><sb:author><ce:given-name>W.</ce:given-name><ce:surname>Creighton</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Pathogenesis of unexplained drowning: new insights from a molecular autopsy</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Mayo Clin Proc</sb:maintitle></sb:title><sb:volume-nr>80</sb:volume-nr></sb:series><sb:date>2005</sb:date></sb:issue><sb:pages><sb:first-page>596</sb:first-page><sb:last-page>600</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib70"><ce:label>70</ce:label><sb:reference><sb:contribution><sb:authors><sb:author><ce:given-name>N.H.</ce:given-name><ce:surname>Prakken</ce:surname></sb:author><sb:author><ce:given-name>B.K.</ce:given-name><ce:surname>Velthuis</ce:surname></sb:author><sb:author><ce:given-name>M.J.</ce:given-name><ce:surname>Cramer</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Advances in cardiac imaging: the role of magnetic imaging and computed tomography in identifying athletes at risk</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Br J Sports Med</sb:maintitle></sb:title><sb:volume-nr>43</sb:volume-nr></sb:series><sb:date>2009</sb:date></sb:issue><sb:pages><sb:first-page>677</sb:first-page><sb:last-page>684</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference></ce:bibliography-sec></ce:bibliography></tail></article>